Back
Galmed Pharmaceuticals Vs. Apogee Enterprises Industry Stock Comparison
Sell
11
GLMD
Galmed Pharmaceuticals
Last Price:
0.28
Seasonality Move:
-13.25%
Buy
61
APOG
Apogee Enterprises
Last Price:
63.05
Seasonality Move:
0.92%
Sell
11
Galmed Pharmaceuticals (GLMD)
is a Sell
Is Galmed Pharmaceuticals a Buy, Sell or Hold?
- The current Galmed Pharmaceuticals [GLMD] share price is $0.28. The Score for GLMD is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- GLMD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
61
Apogee Enterprises (APOG)
is a Buy
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $63.06. The Score for APOG is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- APOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLMD Stock Price Chart
What is Galmed Pharmaceuticals's stock price today?
-
The Galmed Pharmaceuticals share price today is $0.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLMD is experiencing slight selling pressure.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $63.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APOG is experiencing slight selling pressure.
GLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 29.98 | Sell |
Chaikin Money Flow: | -73707 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.31 - 0.37) | Sell |
Bollinger Bands (100): | (0.33 - 0.39) | Sell |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 52.89 | Buy |
Chaikin Money Flow: | -136947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.7 - 64.72) | Buy |
Bollinger Bands (100): | (56.24 - 63.86) | Buy |
GLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.31 | Sell |
20-day SMA: | 0.33 | Sell |
50-day SMA: | 0.37 | Sell |
200-day SMA: | 0.4 | Sell |
8-day EMA: | 0.3 | Sell |
20-day EMA: | 0.33 | Sell |
50-day EMA: | 0.35 | Sell |
200-day EMA: | 0.99 | Sell |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.18 | Buy |
20-day SMA: | 61.94 | Buy |
50-day SMA: | 63.23 | Sell |
200-day SMA: | 54.21 | Buy |
8-day EMA: | 61.73 | Buy |
20-day EMA: | 62.13 | Buy |
50-day EMA: | 62.04 | Buy |
200-day EMA: | 56.06 | Buy |
Galmed Pharmaceuticals Earnings Growth & GLMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.67 per share, and an increase next year of $0.11 per share.
Galmed Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |